BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 28100902)

  • 1. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
    Shen J; Zhu Y; Wu W; Zhang L; Ju H; Fan Y; Zhu Y; Luo J; Liu P; Zhou N; Lu K; Zhang N; Li D; Liu L
    Med Sci Monit; 2017 Jan; 23():315-324. PubMed ID: 28100902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-operative Neutrophils/Lymphocyte Ratio in Rectal Cancer Patients with Preoperative Chemoradiotherapy.
    Lino-Silva LS; Salcedo-Hernández RA; Ruiz-García EB; García-Pérez L; Herrera-Gómez Á
    Med Arch; 2016 Jul; 70(4):256-260. PubMed ID: 27703284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Lee JH; Song C; Kang SB; Lee HS; Lee KW; Kim JS
    Anticancer Res; 2018 Dec; 38(12):6905-6910. PubMed ID: 30504408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy.
    Sung S; Son SH; Park EY; Kay CS
    PLoS One; 2017; 12(3):e0173955. PubMed ID: 28291841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact of Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Low Rectal Cancer Treated with Preoperative Chemoradiotherapy.
    Nagasaki T; Akiyoshi T; Fujimoto Y; Konishi T; Nagayama S; Fukunaga Y; Ueno M
    Dig Surg; 2015; 32(6):496-503. PubMed ID: 26544755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Value of the Neutrophil-Lymphocyte Ratio for Tumor Regression Grade and Prognosis of Local Advanced Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
    Li S; Wang D; Wei R; Yu G; Wang X; Jiang Z
    Technol Cancer Res Treat; 2023; 22():15330338231202611. PubMed ID: 37807729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.
    Shen L; Zhang H; Liang L; Li G; Fan M; Wu Y; Zhu J; Zhang Z
    Radiat Oncol; 2014 Dec; 9():295. PubMed ID: 25518933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of Preoperative Plasma Fibrinogen and Neutrophil-to-Lymphocyte Ratio (the F-NLR Score) as a Prognostic Marker of Locally Advanced Rectal Cancer Following Preoperative Chemoradiotherapy.
    Sun Y; Zhang Y; Huang Z; Lin H; Lu X; Huang Y; Chi P
    World J Surg; 2020 Jun; 44(6):1975-1984. PubMed ID: 32020327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
    Dudani S; Marginean H; Tang PA; Monzon JG; Raissouni S; Asmis TR; Goodwin RA; Gotfrit J; Cheung WY; Vickers MM
    BMC Cancer; 2019 Jul; 19(1):664. PubMed ID: 31277604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Inflammatory Response After Preoperative Chemoradiotherapy Can Affect Oncologic Outcomes in Locally Advanced Rectal Cancer.
    Lee IH; Hwang S; Lee SJ; Kang BW; Baek D; Kim HJ; Park SY; Park JS; Choi GS; Kim JC; Cho SH; Kim JG
    Anticancer Res; 2017 Mar; 37(3):1459-1465. PubMed ID: 28314318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil-to-lymphocyte ratio: a hidden gem in predicting neoadjuvant treatment response in locally advanced rectal cancer?
    Andras D; Crisan D; Craciun R; Nemes A; Caziuc A; Drasovean R; Seicean R; Scurtu R; Bințințan V; Eniu D; Coman I; Dindelegan G
    J BUON; 2020; 25(3):1436-1442. PubMed ID: 32862587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-to-Lymphocyte Ratio in Rectal Cancer-Novel Biomarker of Tumor Immunogenicity During Radiotherapy or Confounding Variable?
    Braun LH; Baumann D; Zwirner K; Eipper E; Hauth F; Peter A; Zips D; Gani C
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil-to-Lymphocyte Ratio (NLR) as a Poor Predictive Biomarker for Pathological Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Prospective Study.
    Novin K; Fadavi P; Mortazavi N; Sanei M; Khoshbakht Ahmadi H; Barahman M; Noori R; Hoveidamanesh S; Shahin M; Taghizadeh-Hesary F
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):61-67. PubMed ID: 36708552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of pretreatment systemic inflammatory markers in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy.
    Zhang Y; Liu X; Xu M; Chen K; Li S; Guan G
    Sci Rep; 2020 May; 10(1):8017. PubMed ID: 32415197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Neutrophil-to-lymphocyte Ratio on the Effect of CRT for Patients With Rectal Cancer.
    Ishikawa D; Nishi M; Takasu C; Kashihara H; Tokunaga T; Higashijima J; Yoshikawa K; Shimada M
    In Vivo; 2020; 34(2):863-868. PubMed ID: 32111796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer.
    Duque-Santana V; López-Campos F; Martin-Martin M; Valero M; Zafra-Martín J; Couñago F; Sancho S
    Oncology; 2023; 101(6):349-357. PubMed ID: 36273439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
    Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Mohri Y; Kusunoki M
    Anticancer Res; 2013 Nov; 33(11):5065-74. PubMed ID: 24222151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of neutrophil-to-lymphocyte ratio, radiotherapy fractionation/technique, and risk of development of distant metastasis among patients with locally advanced rectal cancer.
    Yang G; Chang JS; Choi JE; Baek ES; Kim SS; Byun HK; Cho Y; Koom WS; Yang SY; Min BS; Shin SJ
    Radiat Oncol; 2022 May; 17(1):100. PubMed ID: 35597954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic inflammation-based predictors of pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
    Xu N; Li W; Huang F; Yang J; Wen Z; Yin L; Zhang Y; Zhao J; Zhou R; Yang J
    J Cancer Res Ther; 2022 Apr; 18(2):438-444. PubMed ID: 35645112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of persistent lower neutrophil-to-lymphocyte ratio during preoperative chemoradiotherapy in locally advanced rectal cancer patients: A propensity score matching analysis.
    Cha YJ; Park EJ; Baik SH; Lee KY; Kang J
    PLoS One; 2019; 14(3):e0214415. PubMed ID: 30901357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.